Magic Medicine

Overview

In 2012, a group of medical researchers embarked on an ambitious exploration into the effects of psilocybin, the active compound in magic mushrooms, on individuals grappling with severe depression. After navigating a complex maze of regulations and ethical considerations, they spent three years securing the required approvals to conduct their groundbreaking study. Their journey not only delves into the potential therapeutic benefits of psychedelics but also raises profound questions about mental health treatment and the boundaries of medical science.